Affiliation: Odense University Hospital; Pharma Medico A/S

Dr. Shokouh earned his MD in 2010 when he started working at a WHO-collaborating cardiovascular research institute as a clinical researcher and physician. His field of research was the prevention and treatment of metabolic syndrome in high risk individuals, in which he designed and conducted a long-term clinical trial.

After winning a doctoral grant from Novo Nordisk Foundation via the Danish Diabetes Academy in 2013, Dr. Shokouh moved to Denmark to continue his studies at Prof. Kjeld Hermansen’s lab in the Department of Endocrinology and Internal Medicine, Aarhus University Hospital. His PhD research was focused on using nutraceuticals to prevent obesity-induced type-2 diabetes and non-alcoholic fatty liver disease in vivo using a range of imaging, analytical chemistry, and genetic methods. His main fields of interest are the pharmacotherapy of obesity and metabolic syndrome and the pathophysiology of obesity-induced insulin resistance.

After graduation, Dr. Shokouh continued his career as a pharmaceutical medical advisor and specialist. He is currently working in a Danish pharmaceutical company and is responsible for the scientific and clinical support of several products.